Nektar Therapeutics
(NAS:NKTR)
$
1.35
0.145 (12.03%)
Market Cap: 248.51 Mil
Enterprise Value: 89.37 Mil
PE Ratio: 0
PB Ratio: 3.12
GF Score: 56/100 Nektar Therapeutics (NKTR) Transcripts
- Q4 2023 Nektar Therapeutics Earnings Call TranscriptMar 04, 2024$0.9 (+15.38%)Earnings
- Nektar Therapeutics at JPMorgan Healthcare Conference TranscriptJan 11, 2024
- Q3 2023 Nektar Therapeutics Earnings Call TranscriptNov 07, 2023$0.548 (+3.44%)Earnings
- Nektar Therapeutics to Host Virtual Investor & Analyst Event TranscriptSep 13, 2023
- Q2 2023 Nektar Therapeutics Earnings Call TranscriptAug 08, 2023$1 (-1.96%)Earnings
- Nektar Therapeutics at Goldman Sachs Healthcare Conference TranscriptJun 14, 2023
- Q1 2023 Nektar Therapeutics Earnings Call TranscriptMay 09, 2023$0.7687 (-0.17%)Earnings
- Nektar Therapeutics Analyst and Investor Call TranscriptFeb 23, 2023
- Nektar Therapeutics at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- Nektar Therapeutics To Host Investor & Analyst Event TranscriptDec 12, 2022
- Q3 2022 Nektar Therapeutics Earnings Call TranscriptNov 03, 2022$3.56 (-2.20%)Earnings
- Q2 2022 Nektar Therapeutics Earnings Call TranscriptAug 04, 2022$4.42 (-1.12%)Earnings
- Nektar Therapeutics Corporate Call for Analysts and Investors to Outline New Strategic Plan TranscriptApr 25, 2022
- Nektar Therapeutics to Host Webcast Conference Call for Analysts & Investors Following Announcement of Update from Bristol-Myers Squibb and Nektar on the PIVOT-IO-001 Phase 3 Trial TranscriptMar 14, 2022
- Q4 2021 Nektar Therapeutics Earnings Call TranscriptFeb 28, 2022$10.24 (+2.61%)Earnings
- Nektar Therapeutics at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2022
- Nektar Therapeutics ESMO-IO Congress Call TranscriptDec 06, 2021
- Nektar Therapeutics Investor and Analyst Call at SITC TranscriptNov 12, 2021
- Q3 2021 Nektar Therapeutics Earnings Call TranscriptNov 04, 2021$16.65 (-2.17%)Earnings
- Q2 2021 Nektar Therapeutics Earnings Call TranscriptAug 05, 2021$15.87 (+1.60%)Earnings
- Nektar Therapeutics Annual Shareholders Meeting TranscriptJun 10, 2021
- Nektar Therapeutics at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 08, 2021
- Q1 2021 Nektar Therapeutics Earnings Call TranscriptMay 06, 2021$18.52 (-0.86%)Earnings
- Q4 2020 Nektar Therapeutics Earnings Call TranscriptFeb 25, 2021$22.44 (-1.45%)Earnings
- Nektar Therapeutics at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Nektar Therapeutics Analysts Call with Expert Oncologist Panel During 2020 Society for Immunotherapy of Cancer (SITC) 35th Annual Meeting TranscriptNov 11, 2020
- Q3 2020 Nektar Therapeutics Earnings Call TranscriptNov 05, 2020$16.89 (-0.47%)Earnings
- Nektar Therapeutics Webcast Conference Call for Analysts and Investors for 2020 American College of Rheumatology (ACR) Congress TranscriptNov 04, 2020
- Nektar Therapeutics Corporate Call - COVID Analyst Event TranscriptOct 27, 2020
- Q2 2020 Nektar Therapeutics Earnings Call TranscriptAug 06, 2020$21.51 (-1.10%)Earnings
- Nektar Therapeutics Annual Shareholders Meeting TranscriptJun 17, 2020
- Nektar Therapeutics Conference Call for Analysts at EULAR TranscriptJun 05, 2020
- Nektar Therapeutics at Jefferies Healthcare Conference (Virtual) TranscriptJun 03, 2020
- Q1 2020 Nektar Therapeutics Earnings Call TranscriptMay 07, 2020$19.88 (+1.79%)Earnings
- Nektar Therapeutics at Cowen HealthCare Conference TranscriptMar 03, 2020
- Q4 2019 Nektar Therapeutics Earnings Call TranscriptFeb 27, 2020$20.53 (-4.09%)Earnings
- Nektar Therapeutics at JPMorgan Healthcare Conference TranscriptJan 13, 2020
- Nektar Therapeutics at Jefferies London Healthcare Conference TranscriptNov 20, 2019
- Nektar Therapeutics Analyst and Investors Call with Melanoma Specialist During 2019 Society for Immunotherapy of Cancer 34th Annual Meeting TranscriptNov 10, 2019
- Q3 2019 Nektar Therapeutics Earnings Call TranscriptNov 06, 2019$18.1 (-2.37%)Earnings
- Nektar Therapeutics preliminary results from the TNBC cohort of the Ph1/2 PIVOT-02 study TranscriptSep 26, 2019
- Q2 2019 Nektar Therapeutics Earnings Call TranscriptAug 08, 2019$29.57 (+2.67%)Earnings
- Nektar Therapeutics Webcast Conference Call with Immunology Specialists for Analysts at EULAR TranscriptJun 13, 2019
- Q1 2019 Nektar Therapeutics Earnings Call TranscriptMay 08, 2019$32.98 (+2.81%)Earnings
- Nektar Therapeutics at Cowen Health Care Conference TranscriptMar 12, 2019
- 1